Dysregulated nitric oxide signaling as a candidate mechanism of fragile X syndrome and other neuropsychiatric disorders

Frontiers in Genetics

Volumn 5, Issue JUL, 2014, Pages

  Colvin, Steven M ^a   Kwan, Kenneth Y ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Anterior cingulate cortex; Broca's speech and language area; Cerebral neocortex; Human fetal brain; Neural circuit assembly; Neurodevelopmental disorders; Nitric oxide signaling; Pyramidal neurons

Indexed keywords

ARBACLOFEN; FENOBAM; FRAGILE X MENTAL RETARDATION PROTEIN; MAVOGLURANT; METABOTROPIC RECEPTOR; MINOCYCLINE; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NNZ 2566; NPL 2009; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; SAPROPTERIN; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

AGGRESSION; ANTERIOR CINGULATE; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; COMORBIDITY; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; IMPULSIVENESS; MAJOR DEPRESSION; MENTAL DISEASE; MOLECULARLY TARGETED THERAPY; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RNA TRANSLATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

EID: 84906221248     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00239     Document Type: Article

References (176)

1. Abbeduto, L., Brady, N., and Kover, S. T. (2007). Language development and fragile X syndrome: profiles, syndrome-specificity, and within-syndrome differences. Ment. Retard. Dev. Disabil. Res. Rev. 13, 36-46. doi: 10.1002/mrdd.20142
2. Abitbol, M., Menini, C., Delezoide, A. L., Rhyner, T., Vekemans, M., and Mallet, J. (1993). Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat. Genet. 4, 147-153. doi: 10.1038/ng0693-147
3. Alcamo, E. A., Chirivella, L., Dautzenberg, M., Dobreva, G., Fariñas, I., Grosschedl, R.,et al. (2008). Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 57, 364-377. doi: 10.1016/j.neuron.2007.12.012
4. Antar, L. N., Afroz, R., Dictenberg, J. B., Carroll, R. C., and Bassell, G. J. (2004). Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J. Neurosci. 24, 2648-2655. doi: 10.1523/JNEUROSCI.0099-04.2004
5. Arlotta, P., Molyneaux, B. J., Chen, J., Inoue, J., Kominami, R., and Macklis, J. D. (2005). Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45, 207-221. doi: 10.1016/j.neuron.2004.12.036
6. Ashley, C. T., Wilkinson, K. D., Reines, D., and Warren, S. T. (1993). FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262, 563-566. doi: 10.1126/science.7692601
7. Bacon, C., and Rappold, G. A. (2012). The distinct and overlapping phenotypic spectra of FOXP1 and FOXP2 in cognitive disorders. Hum. Genet. 131, 1687-1698. doi: 10.1007/s00439-012-1193-z
8. Bagni, C., and Greenough, W. T. (2005). From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 6, 376-387. doi: 10.1038/nrn1667
9. Bakker, C. E., de Diego Otero, Y., Bontekoe, C., Raghoe, P., Luteijn, T., Hoogeveen, A. T.,et al. (2000). Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp. Cell Res. 258, 162-170. doi: 10.1006/excr.2000.4932
10. Bassell, G. J., and Warren, S. T. (2008). Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60, 201-214. doi: 10.1016/j.neuron.2008.10.004
11. Bear, M. F., Huber, K. M., and Warren, S. T. (2004). The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370-377. doi: 10.1016/j.tins.2004.04.009
12. Bechara, E. G., Didiot, M. C., Melko, M., Davidovic, L., Bensaid, M., Martin, P.,et al. (2009). A novel function for fragile X mental retardation protein in translational activation. PLoS Biol. 7:e16. doi: 10.1371/journal.pbio.1000016
13. Berry-Kravis, E. (2014). Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome. Pediatr. Neurol. 50, 297-302. doi: 10.1016/j.pediatrneurol.2013.12.001
14. Berry-Kravis, E., Hessl, D., Coffey, S., Hervey, C., Schneider, A., Yuhas, J.,et al. (2009). A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J. Med. Genet. 46, 266-271. doi: 10.1136/jmg.2008.063701
15. Berry-Kravis, E. M., Hessl, D., Rathmell, B., Zarevics, P., Cherubini, M., Walton-Bowen, K.,et al. (2012). Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci. Transl. Med. 4, 152ra127. doi: 10.1126/scitranslmed.3004214
16. Bilousova, T. V., Dansie, L., Ngo, M., Aye, J., Charles, J. R., Ethell, D. W.,et al. (2009). Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J. Med. Genet. 46, 94-102. doi: 10.1136/jmg.2008.061796
17. Boolell, M., Allen, M. J., Ballard, S. A., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M.,et al. (1996). Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. 8, 47-52.
18. Bourgeois, J. P. (1997). Synaptogenesis, heterochrony and epigenesis in the mammalian neocortex. Acta Paediatr. Suppl. 422, 27-33. doi: 10.1111/j.1651-2227.1997.tb18340.x
19. Bray, S., Hirt, M., Jo, B., Hall, S. S., Lightbody, A. A., Walter, E.,et al. (2011). Aberrant frontal lobe maturation in adolescents with fragile X syndrome is related to delayed cognitive maturation. Biol. Psychiatry 70, 852-858. doi: 10.1016/j.biopsych.2011.05.038
20. Bredt, D. S., and Snyder, S. H. (1994). Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63, 175-195. doi: 10.1146/annurev.bi.63.070194.001135
21. Brenman, J. E., and Bredt, D. S. (1997). Synaptic signaling by nitric oxide. Curr. Opin. Neurobiol. 7, 374-378. doi: 10.1016/S0959-4388(97)80065-7
22. Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R.,et al. (1996). Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84, 757-767. doi: 10.1016/S0092-8674(00)81053-3
23. Britanova, O., de Juan Romero, C., Cheung, A., Kwan, K. Y., Schwark, M., Gyorgy, A.,et al. (2008). Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. Neuron 57, 378-392. doi: 10.1016/j.neuron.2007.12.028
24. Brown, J. W., and Braver, T. S. (2005). Learned predictions of error likelihood in the anterior cingulate cortex. Science 307, 1118-1121. doi: 10.1126/science.1105783
25. Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A.,et al. (2001). Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477-487. doi: 10.1016/S0092-8674(01)00568-2
26. Burette, A., Zabel, U., Weinberg, R. J., Schmidt, H. H., and Valtschanoff, J. G. (2002). Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J. Neurosci. 22, 8961-8970.
27. Bush, G., Frazier, J. A., Rauch, S. L., Seidman, L. J., Whalen, P. J., Jenike, M. A.,et al. (1999). Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol. Psychiatry 45, 1542-1552. doi: 10.1016/S0006-3223(99)00083-9
28. Bush, G., Vogt, B. A., Holmes, J., Dale, A. M., Greve, D., Jenike, M. A.,et al. (2002). Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc. Natl. Acad. Sci. U.S.A. 99, 523-528. doi: 10.1073/pnas.012470999
29. Buxhoeveden, D. P., and Casanova, M. F. (2002). The minicolumn hypothesis in neuroscience. Brain 125, 935-951. doi: 10.1093/brain/awf110
30. Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., and Stella, A. M. (2007). Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8, 766-775. doi: 10.1038/nrn2214
31. Carroll, L. S., and Owen, M. J. (2009). Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med. 1, 102. doi: 10.1186/gm102
32. Casanova, M. F., Buxhoeveden, D., and Gomez, J. (2003). Disruption in the inhibitory architecture of the cell minicolumn: implications for autism. Neuroscientist 9, 496-507. doi: 10.1177/1073858403253552
33. Casanova, M. F., Buxhoeveden, D. P., Switala, A. E., and Roy, E. (2002). Minicolumnar pathology in autism. Neurology 58, 428-432. doi: 10.1212/WNL.58.3.428
34. Clancy, B., Kersh, B., Hyde, J., Darlington, R. B., Anand, K. J., and Finlay, B. L. (2007). Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 5, 79-94. doi: 10.1385/NI:5:1:79
35. Colantuoni, C., Lipska, B. K., Ye, T., Hyde, T. M., Tao, R., Leek, J. T.,et al. (2011). Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519-523. doi: 10.1038/nature10524
36. Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J.,et al. (1997). Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U.S.A. 94, 5401-5404. doi: 10.1073/pnas.94.10.5401
37. Contestabile, A. (2000). Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Brain Res. Rev. 32, 476-509. doi: 10.1016/S0165-0173(00)00018-7
38. Crottaz-Herbette, S., and Menon, V. (2006). Where and when the anterior cingulate cortex modulates attentional response: combined fMRI and ERP evidence. J. Cogn. Neurosci. 18, 766-780. doi: 10.1162/jocn.2006.18.5.766
39. Darnell, J. C., Jensen, K. B., Jin, P., Brown, V., Warren, S. T., and Darnell, R. B. (2001). Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489-499. doi: 10.1016/S0092-8674(01)00566-9
40. Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y., Mele, A., Fraser, C. E.,et al. (2011). FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261. doi: 10.1016/j.cell.2011.06.013
41. Davey, C. G., Harrison, B. J., Yücel, M., and Allen, N. B. (2012). Regionally specific alterations in functional connectivity of the anterior cingulate cortex in major depressive disorder. Psychol. Med. 42, 2071-2081. doi: 10.1017/S0033291712000323
42. De Fossé, L., Hodge, S. M., Makris, N., Kennedy, D. N., Caviness, V. S., McGrath, L.,et al. (2004). Language-association cortex asymmetry in autism and specific language impairment. Ann. Neurol. 56, 757-766. doi: 10.1002/ana.20275
43. de Graaf-Peters, V. B., and Hadders-Algra, M. (2006). Ontogeny of the human central nervous system: what is happening when? Early Hum. Dev. 82, 257-266. doi: 10.1016/j.earlhumdev.2005.10.013
44. Devinsky, O., Morrell, M. J., and Vogt, B. A. (1995). Contributions of anterior cingulate cortex to behaviour. Brain 118(Pt 1), 279-306. doi: 10.1093/brain/118.1.279
45. Devys, D., Lutz, Y., Rouyer, N., Bellocq, J. P., and Mandel, J. L. (1993). The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat. Genet. 4, 335-340. doi: 10.1038/ng0893-335
46. Dinstein, I., Pierce, K., Eyler, L., Solso, S., Malach, R., Behrmann, M.,et al. (2011). Disrupted neural synchronization in toddlers with autism. Neuron 70, 1218-1225. doi: 10.1016/j.neuron.2011.04.018
47. Drevets, W. C., Savitz, J., and Trimble, M. (2008). The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 13, 663-681.
48. Dölen, G., Osterweil, E., Rao, B. S., Smith, G. B., Auerbach, B. D., Chattarji, S.,et al. (2007). Correction of fragile X syndrome in mice. Neuron 56, 955-962. doi: 10.1016/j.neuron.2007.12.001
49. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 14863-14868. doi: 10.1073/pnas.95.25.14863
50. Erickson, C. A., Veenstra-Vanderweele, J. M., Melmed, R. D., McCracken, J. T., Ginsberg, L. D., Sikich, L.,et al. (2014). STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J. Autism Dev. Disord. 44, 958-964. doi: 10.1007/s10803-013-1963-z
51. Etkin, A., Egner, T., and Kalisch, R. (2011). Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn. Sci. 15, 85-93. doi: 10.1016/j.tics.2010.11.004
52. Feng, Y., Gutekunst, C. A., Eberhart, D. E., Yi, H., Warren, S. T., and Hersch, S. M. (1997). Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17, 1539-1547.
53. Ferreira, M. A., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L.,et al. (2008). Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 40, 1056-1058. doi: 10.1038/ng.209
54. Fisher, S. E., and Scharff, C. (2009). FOXP2 as a molecular window into speech and language. Trends Genet. 25, 166-177. doi: 10.1016/j.tig.2009.03.002
55. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P.,et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184. doi: 10.1038/nature12929
56. Frye, R. E., DeLatorre, R., Taylor, H. B., Slattery, J., Melnyk, S., Chowdhury, N.,et al. (2013). Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study. Transl. Psychiatry 3, e237. doi: 10.1038/tp.2013.14
57. Fähling, M., Mrowka, R., Steege, A., Kirschner, K. M., Benko, E., Förstera, B.,et al. (2009). Translational regulation of the human achaete-scute homologue-1 by fragile X mental retardation protein. J. Biol. Chem. 284, 4255-4266. doi: 10.1074/jbc.M807354200
58. Gabel, L. A., Won, S., Kawai, H., McKinney, M., Tartakoff, A. M., and Fallon, J. R. (2004). Visual experience regulates transient expression and dendritic localization of fragile X mental retardation protein. J. Neurosci. 24, 10579-10583. doi: 10.1523/JNEUROSCI.2185-04.2004
59. Gantois, I., Pop, A. S., de Esch, C. E., Buijsen, R. A., Pooters, T., Gomez-Mancilla, B.,et al. (2013). Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice. Behav. Brain Res. 239, 72-79. doi: 10.1016/j.bbr.2012.10.059
60. Gao, S. F., Qi, X. R., Zhao, J., Balesar, R., Bao, A. M., and Swaab, D. F. (2013). Decreased NOS1 expression in the anterior cingulate cortex in depression. Cereb. Cortex 23, 2956-2964. doi: 10.1093/cercor/bhs285
61. Garber, K. (2007). Neuroscience. Autism's cause may reside in abnormalities at the synapse. Science 317, 190-191. doi: 10.1126/science.317.5835.190
62. García-Barroso, C., Ricobaraza, A., Pascual-Lucas, M., Unceta, N., Rico, A. J., Goicolea, M. A.,et al. (2013). Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD. Neuropharmacology 64, 114-123. doi: 10.1016/j.neuropharm.2012.06.052
63. Garthwaite, J. (2008). Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci. 27, 2783-2802. doi: 10.1111/j.1460-9568.2008.06285.x
64. Garthwaite, J., and Boulton, C. L. (1995). Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57, 683-706. doi: 10.1146/annurev.ph.57.030195.003343
65. Geschwind, D., and Konopka, G. (2009). Neuroscience in the era of functional genomics and systems biology. Nature 461, 908-915. doi: 10.1038/nature08537
66. Geschwind, D. H., and Rakic, P. (2013). Cortical evolution: judge the brain by its cover. Neuron 80, 633-647. doi: 10.1016/j.neuron.2013.10.045
67. Goldman-Rakic, P. S. (1996). The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351, 1445-1453. doi: 10.1098/rstb.1996.0129
68. Gross, C., Yao, X., Pong, D. L., Jeromin, A., and Bassell, G. J. (2011). Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2. J. Neurosci. 31, 5693-5698. doi: 10.1523/JNEUROSCI.6661-10.2011
69. Guan, J., and Gluckman, P. D. (2009). IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions. Br. J. Pharmacol. 157, 881-891. doi: 10.1111/j.1476-5381.2009.00256.x
70. Guan, J., Waldvogel, H. J., Faull, R. L., Gluckman, P. D., and Williams, C. E. (1999). The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats. Neuroscience 89, 649-659. doi: 10.1016/S0306-4522(98)00338-8
71. Gulsuner, S., Walsh, T., Watts, A. C., Lee, M. K., Thornton, A. M., Casadei, S.,et al. (2013). Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 154, 518-529. doi: 10.1016/j.cell.2013.06.049
72. Haas, B. W., Barnea-Goraly, N., Lightbody, A. A., Patnaik, S. S., Hoeft, F., Hazlett, H.,et al. (2009). Early white-matter abnormalities of the ventral frontostriatal pathway in fragile X syndrome. Dev. Med. Child Neurol. 51, 593-599. doi: 10.1111/j.1469-8749.2009.03295.x
73. Haddad, P. M., and Dursun, S. M. (2008). Neurological complications of psychiatric drugs: clinical features and management. Hum. Psychopharmacol. 23(Suppl. 1), 15-26. doi: 10.1002/hup.918
74. Hadley, R. D., Kater, S. B., and Cohan, C. S. (1983). Electrical synapse formation depends on interaction of mutually growing neurites. Science 221, 466-468. doi: 10.1126/science.6867723
75. Hagerman, R., Hoem, G., and Hagerman, P. (2010). Fragile X and autism: intertwined at the molecular level leading to targeted treatments. Mol. Autism 1, 12. doi: 10.1186/2040-2392-1-12
76. Hall, S. S., Jiang, H., Reiss, A. L., and Greicius, M. D. (2013). Identifying large-scale brain networks in fragile X syndrome. JAMA Psychiatry 70, 1215-1223. doi: 10.1001/jamapsychiatry.2013.247
77. Hallak, J. E., Maia-de-Oliveira, J. P., Abrao, J., Evora, P. R., Zuardi, A. W., Crippa, J. A.,et al. (2013). Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry 70, 668-676. doi: 10.1001/jamapsychiatry.2013.1292
78. Harris, S. W., Hessl, D., Goodlin-Jones, B., Ferranti, J., Bacalman, S., Barbato, I.,et al. (2008). Autism profiles of males with fragile X syndrome. Am. J. Ment. Retard. 113, 427-438. doi: 10.1352/2008.113:427-438
79. Henin, A., Micco, J. A., Wozniak, J., Briesch, J. M., Narayan, A. J., and Hirshfeld-Becker, D. R. (2009). Neurocognitive functioning in bipolar disorder. Clin. Psychol. Sci. Pract. 16, 231-250. doi: 10.1111/j.1468-2850.2009.01162.x
80. Henseler, I., Falkai, P., and Gruber, O. (2010). Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms. J. Psychiatr. Res. 44, 364-372. doi: 10.1016/j.jpsychires.2009.09.003
81. Hinds, H. L., Ashley, C. T., Sutcliffe, J. S., Nelson, D. L., Warren, S. T., Housman, D. E.,et al. (1993). Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat. Genet. 3, 36-43. doi: 10.1038/ng0193-36
82. Huber, K. M., Gallagher, S. M., Warren, S. T., and Bear, M. F. (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U.S.A. 99, 7746-7750. doi: 10.1073/pnas.122205699
83. Huber, K. M., Kayser, M. S., and Bear, M. F. (2000). Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288, 1254-1257. doi: 10.1126/science.288.5469.1254
84. Huber, K. M., Roder, J. C., and Bear, M. F. (2001). Chemical induction of mGluR5- and protein synthesis - dependent long-term depression in hippocampal area CA1. J. Neurophysiol. 86, 321-325.
85. Hutsler, J. J., and Zhang, H. (2010). Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309, 83-94. doi: 10.1016/j.brainres.2009.09.120
86. Hölscher, C. (1997). Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 20, 298-303. doi: 10.1016/S0166-2236(97)01065-5
87. Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J.,et al. (2012). De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299. doi: 10.1016/j.neuron.2012.04.009
88. Irwin, S. A., Galvez, R., and Greenough, W. T. (2000). Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb. Cortex 10, 1038-1044. doi: 10.1093/cercor/10.10.1038
89. Jacquemont, S., Berry-Kravis, E., Hagerman, R., von Raison, F., Gasparini, F., Apostol, G.,et al. (2014). The challenges of clinical trials in fragile X syndrome. Psychopharmacology (Berl.) 231, 1237-1250. doi: 10.1007/s00213-013-3289-0
90. Jacquemont, S., Curie, A., des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J.,et al. (2011). Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci. Transl. Med. 3, 64ra1. doi: 10.1126/scitranslmed.3001708
91. Johnson, M. B., Kawasawa, Y. I., Mason, C. E., Krsnik, Z., Coppola, G., Bogdanovic, D.,et al. (2009). Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 62, 494-509. doi: 10.1016/j.neuron.2009.03.027
92. Judas, M., and Cepanec, M. (2007). Adult structure and development of the human fronto-opercular cerebral cortex (Broca's region). Clin. Linguist. Phon. 21, 975-989. doi: 10.1080/02699200701617175
93. Kang, H. J., Kawasawa, Y. I., Cheng, F., Zhu, Y., Xu, X., Li, M.,et al. (2011). Spatio-temporal transcriptome of the human brain. Nature 478, 483-489. doi: 10.1038/nature10523
94. Kaufmann, W. E., and Moser, H. W. (2000). Dendritic anomalies in disorders associated with mental retardation. Cereb. Cortex 10, 981-991. doi: 10.1093/cercor/10.10.981
95. Keller, S. S., Crow, T., Foundas, A., Amunts, K., and Roberts, N. (2009). Broca's area: nomenclature, anatomy, typology and asymmetry. Brain Lang. 109, 29-48. doi: 10.1016/j.bandl.2008.11.005
96. Kim, M. J., Chung, Y. H., Joo, K. M., Oh, G. T., Kim, J., Lee, B.,et al. (2004). Immunohistochemical study of the distribution of neuronal voltage-gated calcium channels in the nNOS knock-out mouse cerebellum. Neurosci. Lett. 369, 39-43. doi: 10.1016/j.neulet.2004.07.047
97. Kindler, S., and Kreienkamp, H. J. (2012). The role of the postsynaptic density in the pathology of the fragile X syndrome. Results Probl. Cell Differ. 54, 61-80. doi: 10.1007/978-3-642-21649-7_5
98. Ko, J. H., Ptito, A., Monchi, O., Cho, S. S., Van Eimeren, T., Pellecchia, G.,et al. (2009). Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study. Neuroimage 46, 516-521. doi: 10.1016/j.neuroimage.2009.02.031
99. Kovács, T., Kelemen, O., and Kéri, S. (2013). Decreased fragile X mental retardation protein (FMRP) is associated with lower IQ and earlier illness onset in patients with schizophrenia. Psychiatry Res. 210, 690-693. doi: 10.1016/j.psychres.2012.12.022
100. Krumm, N., O'Roak, B. J., Shendure, J., and Eichler, E. E. (2014). A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci. 37, 95-105. doi: 10.1016/j.tins.2013.11.005
101. Kuperberg, G. R., West, W. C., Lakshmanan, B. M., and Goff, D. (2008). Functional magnetic resonance imaging reveals neuroanatomical dissociations during semantic integration in schizophrenia. Biol. Psychiatry 64, 407-418. doi: 10.1016/j.biopsych.2008.03.018
102. Kwan, K. Y. (2013). Transcriptional dysregulation of neocortical circuit assembly in ASD. Int. Rev. Neurobiol. 113, 167-205. doi: 10.1016/B978-0-12-418700-9.00006-X
103. Kwan, K. Y., Lam, M. M., Johnson, M. B., Dube, U., Shim, S., Rašin, M. R.,et al. (2012a). Species-dependent posttranscriptional regulation of NOS1 by FMRP in the developing cerebral cortex. Cell 149, 899-911. doi: 10.1016/j.cell.2012.02.060
104. Kwan, K. Y., Sestan, N., and Anton, E. S. (2012b). Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex. Development 139, 1535-1546. doi: 10.1242/dev.069963
105. Lai, C. S., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., and Monaco, A. P. (2001). A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413, 519-523. doi: 10.1038/35097076
106. Leigh, M. J., Nguyen, D. V., Mu, Y., Winarni, T. I., Schneider, A., Chechi, T.,et al. (2013). A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. J. Dev. Behav. Pediatr. 34, 147-155. doi: 10.1097/DBP.0b013e318287cd17
107. Lewis, J. D., Evans, A. C., Pruett, J. R., Botteron, K., Zwaigenbaum, L., Estes, A.,et al. (2014). Network inefficiencies in autism spectrum disorder at 24 months. Transl. Psychiatry 4, e388. doi: 10.1038/tp.2014.24
108. Liebenberg, N., Harvey, B. H., Brand, L., and Brink, C. B. (2010). Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression. Behav. Pharmacol. 21, 540-547. doi: 10.1097/FBP.0b013e32833befe5
109. Liebenberg, N., Harvey, B. H., Brand, L., Wegener, G., and Brink, C. B. (2012). Chronic treatment with the phosphodiesterase type 5 inhibitors sildenafil and tadalafil display anxiolytic effects in Flinders Sensitive Line rats. Metab. Brain Dis. 27, 337-340. doi: 10.1007/s11011-012-9284-z
110. Lu, A. T., Dai, X., Martinez-Agosto, J. A., and Cantor, R. M. (2012). Support for calcium channel gene defects in autism spectrum disorders. Mol. Autism 3, 18. doi: 10.1186/2040-2392-3-18
111. Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., and Wu, C. (2004). Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 5, 793-807. doi: 10.1038/nrn1519
112. Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L.,et al. (1997). Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8, 1057-1061. doi: 10.1097/00001756-199703030-00048
113. McCarthy, S. E., Gillis, J., Kramer, M., Lihm, J., Yoon, S., Berstein, Y.,et al. (2014). De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol. Psychiatry 19, 652-658. doi: 10.1038/mp.2014.29
114. Menon, V., Leroux, J., White, C. D., and Reiss, A. L. (2004). Frontostriatal deficits in fragile X syndrome: relation to FMR1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 101, 3615-3620. doi: 10.1073/pnas.0304544101
115. Miller, E. K., Freedman, D. J., and Wallis, J. D. (2002). The prefrontal cortex: categories, concepts and cognition. Philos. Trans. R Soc. Lond. B Biol. Sci. 357, 1123-1136. doi: 10.1098/rstb.2002.1099
116. Miyashiro, K. Y., Beckel-Mitchener, A., Purk, T. P., Becker, K. G., Barret, T., Liu, L.,et al. (2003). RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37, 417-431. doi: 10.1016/S0896-6273(03)00034-5
117. Morales-Medina, J. C., Mejorada, A., Romero-Curiel, A., and Flores, G. (2007). Alterations in dendritic morphology of hippocampal neurons in adult rats after neonatal administration of N-omega-nitro-L-arginine. Synapse 61, 785-789. doi: 10.1002/syn.20406
118. Mountcastle, V. B. (1997). The columnar organization of the neocortex. Brain 120(Pt 4), 701-722. doi: 10.1093/brain/120.4.701
119. Nikonenko, I., Boda, B., Steen, S., Knott, G., Welker, E., and Muller, D. (2008). PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling. J. Cell Biol. 183, 1115-1127. doi: 10.1083/jcb.200805132
120. Nimchinsky, E. A., Oberlander, A. M., and Svoboda K. (2001). Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 21, 5139-5146.
121. O'Donnell, W. T., and Warren, S. T. (2002). A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25, 315-338. doi: 10.1146/annurev.neuro.25.112701.142909
122. Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A.,et al. (1991). Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097-1102. doi: 10.1126/science.252.5009.1097
123. Oka, M., Itoh, Y., Ukai, Y., and Kimura, K. (1999). Blockade by NS-7, a neuroprotective compound, of both L-type and P/Q-type Ca2+ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal culture. J. Neurochem. 72, 1315-1322. doi: 10.1046/j.1471-4159.1999.0721315.x
124. Paribello, C., Tao, L., Folino, A., Berry-Kravis, E., Tranfaglia, M., Ethell, I. M.,et al. (2010). Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol. 10:91. doi: 10.1186/1471-2377-10-91
125. Parikshak, N. N., Luo, R., Zhang, A., Won, H., Lowe, J. K., Chandran, V.,et al. (2013). Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155, 1008-1021. doi: 10.1016/j.cell.2013.10.031
126. Paus, T., Petrides, M., Evans, A. C., and Meyer, E. (1993). Role of the human anterior cingulate cortex in the control of oculomotor, manual, and speech responses: a positron emission tomography study. J. Neurophysiol. 70, 453-469.
127. Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J. E., and Woolfrey, K. M. (2011). Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285-293. doi: 10.1038/nn.2741
128. Peça, J., Ting, J., and Feng, G. (2011). SnapShot: autism and the synapse. Cell 147, 706-706.e1. doi: 10.1016/j.cell.2011.10.015
129. Picard, N., and Strick, P. L. (1996). Motor areas of the medial wall: a review of their location and functional activation. Cereb. Cortex 6, 342-353. doi: 10.1093/cercor/6.3.342
130. Pierce, K., and Redcay, E. (2008). Fusiform function in children with an autism spectrum disorder is a matter of "who." Biol. Psychiatry 64, 552-560. doi: 10.1016/j.biopsych.2008.05.013
131. Pinto, D., Delaby, E., Merico, D., Barbosa, M., Merikangas, A., Klei, L.,et al. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet. 94, 677-694. doi: 10.1016/j.ajhg.2014.03.018
132. Pop, A. S., Gomez-Mancilla, B., Neri, G., Willemsen, R., and Gasparini, F. (2014). Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development. Psychopharmacology (Berl.) 231, 1217-1226. doi: 10.1007/s00213-013-3330-3
133. Power, J. D., Cohen, A. L., Nelson, S. M., Wig, G. S., Barnes, K. A., Church, J. A.,et al. (2011). Functional network organization of the human brain. Neuron 72, 665-678. doi: 10.1016/j.neuron.2011.09.006
134. Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P. C.,et al. (2014). A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185-190. doi: 10.1038/nature12975
135. Quidé, Y., Witteveen, A. B., El-Hage, W., Veltman, D. J., and Olff, M. (2012). Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic review. Neurosci. Biobehav. Rev. 36, 626-644. doi: 10.1016/j.neubiorev.2011.09.004
136. Rajkowska, G., Halaris, A., and Selemon, L. D. (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry 49, 741-752. doi: 10.1016/S0006-3223(01)01080-0
137. Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y.,et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45, 1085-1098. doi: 10.1016/S0006-3223(99)00041-4
138. Reif, A., Jacob, C. P., Rujescu, D., Herterich, S., Lang, S., Gutknecht, L.,et al. (2009). Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch. Gen. Psychiatry 66, 41-50. doi: 10.1001/archgenpsychiatry.2008.510
139. Rogers, S. J., Wehner, D. E., and Hagerman, R. (2001). The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J. Dev. Behav. Pediatr. 22, 409-417. doi: 10.1097/00004703-200112000-00008
140. Ronesi, J. A., and Huber, K. M. (2008). Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse. Sci. Signal. 1, pe6. doi: 10.1126/stke.15pe6
141. Rutten, K., Vente, J. D., Sik, A., Ittersum, M. M., Prickaerts, J., and Blokland, A. (2005). The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices. Behav. Brain Res. 164, 11-16. doi: 10.1016/j.bbr.2005.04.021
142. Salgado-Pineda, P., Landin-Romero, R., Fakra, E., Delaveau, P., Amann, B. L., and Blin, O. (2014). Structural abnormalities in schizophrenia: further evidence on the key role of the anterior cingulate cortex. Neuropsychobiology 69, 52-58. doi: 10.1159/000356972
143. Sánchez-Islas, E., and León-Olea, M. (2004). Nitric oxide synthase inhibition during synaptic maturation decreases synapsin I immunoreactivity in rat brain. Nitric Oxide 10, 141-149. doi: 10.1016/j.niox.2004.04.001
144. Sandner, P., Svenstrup, N., Tinel, H., Haning, H., and Bischoff, E. (2008). Phosphodiesterase 5 inhibitors and erectile dysfunction. Exp. Opin. Ther. Pat. 18, 21-33. doi: 10.1517/13543776.18.1.21
145. Sattler, R., Xiong, Z., Lu, W. Y., Hafner, M., MacDonald, J. F., and Tymianski, M. (1999). Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284, 1845-1848. doi: 10.1126/science.284.5421.1845
146. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976. doi: 10.1038/ng.940
147. Schweimer, J., and Hauber, W. (2006). Dopamine D1 receptors in the anterior cingulate cortex regulate effort-based decision making. Learn. Mem. 13, 777-782. doi: 10.1101/lm.409306
148. Sestieri, C., Corbetta, M., Spadone, S., Romani, G. L., and Shulman, G. L. (2014). Domain-general signals in the cingulo-opercular network for visuospatial attention and episodic memory. J. Cogn. Neurosci. 26, 551-568. doi: 10.1162/jocn_a_00504
149. Smoller, J. W., Craddock, N., Kendler, K., Lee, P. H., Neale, B. M., Nurnberger, J. I.,et al. (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379. doi: 10.1016/S0140-6736(12)62129-1
150. Splawski, I., Yoo, D. S., Stotz, S. C., Cherry, A., Clapham, D. E., and Keating, M. T. (2006). CACNA1H mutations in autism spectrum disorders. J. Biol. Chem. 281, 22085-22091. doi: 10.1074/jbc.M603316200
151. State, M. W., and Šestan, N. (2012). Neuroscience. The emerging biology of autism spectrum disorders. Science 337, 1301-1303. doi: 10.1126/science.1224989
152. Steinert, J. R., Chernova, T., and Forsythe, I. D. (2010). Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 16, 435-452. doi: 10.1177/1073858410366481
153. Stuart, J. M., Segal, E., Koller, D., and Kim, S. K. (2003). A gene-coexpression network for global discovery of conserved genetic modules. Science 302, 249-255. doi: 10.1126/science.1087447
154. Tamm, L., Menon, V., Johnston, C. K., Hessl, D. R., and Reiss, A. L. (2002). fMRI study of cognitive interference processing in females with fragile X syndrome. J. Cogn. Neurosci. 14, 160-171. doi: 10.1162/089892902317236812
155. Todd, P. K., Mack, K. J., and Malter, J. S. (2003). The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc. Natl. Acad. Sci. U.S.A. 100, 14374-14378. doi: 10.1073/pnas.2336265100
156. Tu, P. C., Hsieh, J. C., Li, C. T., Bai, Y. M., and Su, T. P. (2012). Cortico-striatal disconnection within the cingulo-opercular network in schizophrenia revealed by intrinsic functional connectivity analysis: a resting fMRI study. Neuroimage 59, 238-247. doi: 10.1016/j.neuroimage.2011.07.086
157. Uddin, L. Q., and Menon, V. (2009). The anterior insula in autism: under-connected and under-examined. Neurosci. Biobehav. Rev. 33, 1198-1203. doi: 10.1016/j.neubiorev.2009.06.002
158. Uddin, M., Tammimies, K., Pellecchia, G., Alipanahi, B., Hu, P., Wang, Z.,et al. (2014). Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 46, 742-747. doi: 10.1038/ng.2980
159. Uthayathas, S., Parameshwaran, K., Karuppagounder, S. S., Ahuja, M., Dhanasekaran, M., and Suppiramaniam, V. (2013). Selective inhibition of phosphodiesterase 5 enhances glutamatergic synaptic plasticity and memory in mice. Synapse 67, 741-747. doi: 10.1002/syn.21676
160. Vaden, K. I., Kuchinsky, S. E., Cute, S. L., Ahlstrom, J. B., Dubno, J. R., and Eckert, M. A. (2013). The cingulo-opercular network provides word-recognition benefit. J. Neurosci. 33, 18979-18986. doi: 10.1523/JNEUROSCI.1417-13.2013
161. Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A.,et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914. doi: 10.1016/0092-8674(91)90397-H
162. Vincent, A., Heitz, D., Petit, C., Kretz, C., Oberlé, I., and Mandel, J. L. (1991). Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis. Nature 349, 624-626. doi: 10.1038/349624a0
163. Vruwink, M., Schmidt, H. H., Weinberg, R. J., and Burette, A. (2001). Substance P and nitric oxide signaling in cerebral cortex: anatomical evidence for reciprocal signaling between two classes of interneurons. J. Comp. Neurol. 441, 288-301. doi: 10.1002/cne.1413
164. Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M.,et al. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539-543. doi: 10.1126/science.1155174
165. Warren, S. T., Zhang, F., Licameli, G. R., and Peters, J. F. (1987). The fragile X site in somatic cell hybrids: an approach for molecular cloning of fragile sites. Science 237, 420-423. doi: 10.1126/science.3603029
166. Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K.,et al. (1997). Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. U.S.A. 94, 5395-5400. doi: 10.1073/pnas.94.10.5395
167. Weinberger, D. R., Berman, K. F., and Zec, R. F. (1986). Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 43, 114-124. doi: 10.1001/archpsyc.1986.01800020020004
168. Williams, Z. M., Bush, G., Rauch, S. L., Cosgrove, G. R., and Eskandar, E. N. (2004). Human anterior cingulate neurons and the integration of monetary reward with motor responses. Nat. Neurosci. 7, 1370-1375. doi: 10.1038/nn1354
169. Willsey, A. J., Sanders, S. J., Li, M., Dong, S., Tebbenkamp, A. T., Muhle, R. A.,et al. (2013). Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155, 997-1007. doi: 10.1016/j.cell.2013.10.020
170. Workman, A. D., Charvet, C. J., Clancy, B., Darlington, R. B., and Finlay, B. L. (2013). Modeling transformations of neurodevelopmental sequences across mammalian species. J. Neurosci. 33, 7368-7383. doi: 10.1523/JNEUROSCI.5746-12.2013
171. Wray, N. R., Pergadia, M. L., Blackwood, D. H., Penninx, B. W., Gordon, S. D., Nyholt, D. R.,et al. (2012). Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol. Psychiatry 17, 36-48. doi: 10.1038/mp.2010.109
172. Xu, N. J., and Henkemeyer, M. (2012). Ephrin reverse signaling in axon guidance and synaptogenesis. Semin. Cell Dev. Biol. 23, 58-64. doi: 10.1016/j.semcdb.2011.10.024
173. Zalfa, F., Eleuteri, B., Dickson, K. S., Mercaldo, V., De Rubeis, S., di Penta, A.,et al. (2007). A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat. Neurosci. 10, 578-587. doi: 10.1038/nn1893
174. Zhang, J., Guo, J., Zhao, X., Chen, Z., Wang, G., Liu, A.,et al. (2013). Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice. Behav. Brain Res. 250, 230-237. doi: 10.1016/j.bbr.2013.05.017
175. Zikopoulos, B., and Barbas, H. (2013). Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front. Hum. Neurosci. 7:609. doi: 10.3389/fnhum.2013.00609
176. Zoghbi, H. Y. (2003). Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302, 826-830. doi: 10.1126/science.1089071